[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alcon Inc (ALC)

Alcon Inc (ALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,943,178
  • Shares Outstanding, K 494,616
  • Annual Sales, $ 10,401 M
  • Annual Income, $ 980,000 K
  • EBIT $ 1,360 M
  • EBITDA $ 2,551 M
  • 60-Month Beta 0.93
  • Price/Sales 3.04
  • Price/Cash Flow 11.65
  • Price/Book 1.43

Options Overview Details

View History
  • Implied Volatility 27.90% (+0.01%)
  • Historical Volatility 45.00%
  • IV Percentile 52%
  • IV Rank 30.10%
  • IV High 45.50% on 11/11/25
  • IV Low 20.31% on 06/24/25
  • Expected Move (DTE 5) 2.47 (3.95%)
  • Put/Call Vol Ratio 4.66
  • Today's Volume 3,511
  • Volume Avg (30-Day) 710
  • Put/Call OI Ratio 1.48
  • Today's Open Interest 17,568
  • Open Int (30-Day) 12,926
  • Expected Range 60.09 to 65.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.79
  • Number of Estimates 4
  • High Estimate $0.83
  • Low Estimate $0.74
  • Prior Year $0.76
  • Growth Rate Est. (year over year) +3.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
62.40 +0.26%
on 05/08/26
82.36 -24.05%
on 04/17/26
-14.75 (-19.08%)
since 04/08/26
3-Month
62.40 +0.26%
on 05/08/26
87.64 -28.62%
on 02/26/26
-16.27 (-20.64%)
since 02/06/26
52-Week
62.40 +0.26%
on 05/08/26
96.88 -35.43%
on 05/09/25
-33.32 (-34.75%)
since 05/08/25

Most Recent Stories

More News
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds

First-quarter 2026 sales of $2.7 billion, up 10% on a reported basis, or up 6% constant currency 1 (cc), versus first-quarter 2025 ...

ALC : 62.56 (-2.07%)
Can Alcon's New Product Pipeline Finally Offset What the Core Business Isn't Saying?

Barchart Research What to Expect from ALC Earnings ALC Generated May 4, 2026 Current Price $73.48 EPS Estimate $$0.80 Consensus Rating Moderate Buy Average Move 4.64% Can Alcon's New Product Pipeline Finally...

ALC : 62.56 (-2.07%)
Alcon Announces Results of 2026 Annual General Meeting

Shareholders approve all agenda items presented R. Scott Herren elected as new independent member of the Board ...

ALC : 62.56 (-2.07%)
Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada

New partnership raises awareness of dry eye, a condition affecting an estimated 8.5 million Canadians 1 , helping fans stay comfortable throughout the game.

ALC : 62.56 (-2.07%)
Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026

TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL 1,2 ...

ALC : 62.56 (-2.07%)
Alcon Publishes Agenda for 2026 Annual General Meeting

Alcon welcomes its shareholders to its fourth in-person AGM Alcon Board of Directors proposes to elect R. Scott Herren as a new independent Board member...

ALC : 62.56 (-2.07%)
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an agreement with LENSAR, Inc. (NASDAQ: LNSR) to terminate the...

LNSR : 5.64 (+7.84%)
ALC : 62.56 (-2.07%)
Alcon Surpasses 175 Million IOLs Implanted Globally

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs 1,* ...

ALC : 62.56 (-2.07%)
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales

Fourth-quarter 2025 sales of $2.7 billion, up 9% on a reported basis, or up 7% constant currency 1 (cc), versus fourth-quarter 2024 ...

ALC : 62.56 (-2.07%)
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology

Provides excellent end of day comfort even on day 30, ^ helping patients stay in contact lenses † comfortably...

ALC : 62.56 (-2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma...

See More

Key Turning Points

3rd Resistance Point 66.54
2nd Resistance Point 65.68
1st Resistance Point 64.12
Last Price 62.56
1st Support Level 61.70
2nd Support Level 60.84
3rd Support Level 59.28

See More

52-Week High 96.88
Fibonacci 61.8% 83.71
Fibonacci 50% 79.64
Fibonacci 38.2% 75.57
Last Price 62.56
52-Week Low 62.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.